A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml

Nucleic Acids Res. 1997 Aug 1;25(15):2979-84. doi: 10.1093/nar/25.15.2979.

Abstract

The branched DNA hybridization assay has been improved by the inclusion of the novel nucleotides, isoC and isoG, in the amplification sequences to prevent non-specific hybridization. The novel isoC, isoG-containing amplification sequences have no detectable interaction with any natural DNA sequence. The control of non-specific hybridization in turn permits increased signal amplification. Addition of a 14 site preamplifier was found to increase the signal/noise ratio 8-fold. A set of 74 oligonucleotide probes was designed to the consensus HIV POL sequence. The detection limit of this new HIV branched DNA amplifier assay was approximately 50 molecules/ml. The assay was used to measure viral load in 87 plasma samples of HIV- infected patients on triple drug therapy whose RNA titers were <500 molecules/ml. In all 11 patients viral load eventually declined to below the detection limit with the new assay.

MeSH terms

  • Adenosine
  • Anti-HIV Agents / therapeutic use
  • Cytidine / chemistry
  • DNA / chemistry*
  • DNA / metabolism
  • DNA, Viral / analysis
  • Drug Therapy, Combination
  • Guanosine / chemistry
  • HIV
  • HIV Infections / drug therapy
  • HIV Infections / virology
  • Humans
  • Isoquinolines / therapeutic use
  • Lamivudine / therapeutic use
  • Nelfinavir
  • Nucleic Acid Hybridization / methods*
  • RNA, Viral / analysis
  • Sulfonic Acids / therapeutic use
  • Zidovudine / therapeutic use

Substances

  • Anti-HIV Agents
  • DNA, Viral
  • Isoquinolines
  • RNA, Viral
  • Sulfonic Acids
  • Guanosine
  • isoguanosine
  • Lamivudine
  • isocytidine
  • Zidovudine
  • Cytidine
  • DNA
  • Nelfinavir
  • Adenosine